Jayme Locke

Jayme Locke
Professor

Scientist (C), Center for AIDS Research , School of Medicine
Senior Scientist (C), Minority Health & Research Center , General Clinical Research Center
Scientist (C), Center for Clinical and Translational Science (CCTS) , General Clinical Research Center
Professor (P), Surgery - Transplantation , Surgery
Scientist (C), Nutrition Obesity Res Center (NORC) , Nutrition Sciences Research
Scholar (C), Sparkman Center for Global Health , School of Public Health

Overview

Dr. Locke is an abdominal transplant surgeon specializing in innovative strategies for the transplantation of incompatible organs, disparities in access to and outcomes after solid organ transplantation, and transplantation of HIV-infected end-stage patients. Dr. Locke completed an undergraduate degree in biology and chemistry at Duke University and her medical degree at East Carolina University prior to matriculating to Johns Hopkins Hospital where she received training in general surgery and multi-visceral abdominal transplantation. Dr. Locke completed her Master of Public Health degree with an emphasis in biostatistics and epidemiology at the Johns Hopkins Bloomberg School of Public Health.

Her research interests include complex statistical analysis and modeling of transplant outcomes and behavioral research focused on health disparities. She has authored more than 120 articles in peer-reviewed journals and 20 book chapters, and is an NIH R01-funded investigator. In addition, Dr. Locke is a Deputy Editor for the American Journal of Transplantation, and is an editorial board member for Annals of Surgery. She is also a member of the American Society of Transplantation (AST), American Society of Transplant Surgeons (ASTS), and American Society of Nephrology (ASN), as well as, a Fellow of the American College of Surgeons (ACS), Society of University Surgeons (SUS), and the American Surgical Association (ASA). Dr. Locke is the recipient of numerous honors including the UAB Dean’s Excellence Award in Research 2016, and was named the 2016 James IV Association of Surgeons Traveling Fellow, Top 40 Under 40 by the Birmingham Business Journal, AL.com’s 2015 Women Who Shape the State, B-Metro Top Women in Medicine 2017, American College of Surgeons Traveling Fellow 2018, and the AST Clinical Science Faculty Award 2020.

Dr. Locke is currently the Mark H. Deierhoi MD Endowed Professor in Surgery at the University of Alabama at Birmingham, and serves as the Director of the Comprehensive Transplant Institute and Chief of the Division of Abdominal Transplant Surgery. She is also the Associate Chief Medical Officer for UAB Hospital Quality and Patient Safety.

Selected Publications

Academic Article

Year	Title	Altmetric
2022	COVID-19 and transplantation-Data censoring.. American Journal of Transplantation. 2022
2022	First clinical-grade porcine kidney xenotransplant using a human decedent model. American Journal of Transplantation. 22:1037-1053. 2022
2022	Hepatic macrosteatosis in the US pediatric deceased liver donor population. Pediatric Transplantation. 26. 2022
2022	Abnormal time-zero histology is predictive of kidney transplant outcomes. Clinical Transplantation. 2022
2022	Dialysis Nonadherence and Kidney Transplant Outcomes: A Retrospective Cohort Study. American Journal of Kidney Diseases. 2022
2022	Donor-reported barriers to living kidney donor follow-up. Clinical Transplantation. 2022
2022	The “Broken rung” in transplantation surgery 2022
2021	Addressing ethical confusion in deceased donation and transplantation research: the need for dedicated guidance. Transplant International. 34:2459-2468. 2021
2021	Evaluation of Community-Level Vulnerability and Racial Disparities in Living Donor Kidney Transplant. JAMA Surgery. 156:1120-1129. 2021
2021	Impact of Social Vulnerability on Access to Educational Programming Designed to Enhance Living Donation 2021
2021	Editorial: Sensitization and Desensitization in Organ Transplantation. Frontiers in Immunology. 12. 2021
2021	Gender disparities in transplantation. Current Opinion in Organ Transplantation. 26:513-520. 2021
2021	Optimal Timing of Administration of Direct-acting Antivirals for Patients With Hepatitis C-associated Hepatocellular Carcinoma Undergoing Liver Transplantation. Annals of Surgery. 274:613-620. 2021
2021	Significance and innovation: cornerstones of a successful grant application. Surgery. 170:1080-1082. 2021
2021	Survival following simultaneous liver-lung versus liver alone transplantation: Results of the US national experience 2021
2021	New Perspectives on Desensitization in the Current Era - An Overview. Frontiers in Immunology. 12. 2021
2021	APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (contra). Kidney International. 100:30-32. 2021
2021	Obesity is a risk factor for progression to kidney transplant waitlisting after liver transplantation. Clinical Transplantation. 35. 2021
2021	Self-advocacy is associated with lower likelihood of living donor kidney transplantation 2021
2021	Updated Pathway to Micro-elimination of Hepatitis C Virus in the Hemodialysis Population. Kidney International Reports. 6:1788-1798. 2021
2021	Early Outcomes With the Liver-kidney Safety Net. Transplantation. 105:1261-1272. 2021
2021	What Therapeutic Regimen Will Be Optimal for Initial Clinical Trials of Pig Organ Transplantation?. Transplantation. 105:1143-1155. 2021
2021	Analysis of Linguistically and Culturally Tailored Initiatives in Websites of Kidney Transplant Programs in the United States Between 2013-2018 2021
2021	Effects of Geographic Redistribution Policy on Access to Organ Transplant-In Reply. JAMA Surgery. 156:289-290. 2021
2021	Eplet mismatch scores and de novo donor-specific antibody development in simultaneous pancreas-kidney transplantation. Human Immunology. 82:139-146. 2021
2021	Leveraging Frailty to Mitigate Sex-Based Disparities in Access to Liver Transplant: Justice in Allocation. JAMA Surgery. 156:263. 2021
2021	The Living Donor Navigator Program Provides Support Tools for Caregivers 2021
2021	Preexisting melanoma and hematological malignancies, prognosis, and timing to solid organ transplantation: A consensus expert opinion statement. American Journal of Transplantation. 21:475-483. 2021
2021	Pretransplant solid organ malignancy and organ transplant candidacy: A consensus expert opinion statement. American Journal of Transplantation. 21:460-474. 2021
2021	Cardiac Mortality following Kidney Transplantation: Progress Made but Still Room for Improvement. Transplantation. 278-279. 2021
2021	Cognitive mapping as an approach to facilitate organ donation among African Americans 2021
2021	Integrating APOL1 Kidney-risk Variant Testing in Live Kidney Donor Evaluation: An Expert Panel Opinion. Transplantation. 2132-2134. 2021
2021	Patient survival following third time liver transplant in the United States in the MELD era 2021
2021	Pig kidney xenotransplantation: Progress toward clinical trials. Clinical Transplantation. 35. 2021
2021	Suggested Patient Selection Criteria for Initial Clinical Trials of Pig Kidney Xenotransplantation in the United States. Transplantation. 1904-1908. 2021
2020	Human immunodeficiency virus from life taking to life giving: expanding the donor pool by using HIV-positive donors. Current Opinion in Organ Transplantation. 25:626-630. 2020
2020	The tetraspanin CD151 marks a unique population of activated human T cells. Scientific Reports. 10. 2020
2020	Bariatric surgery to achieve transplant in end-stage organ disease patients: A systematic review and meta-analysis 2020
2020	Commentary on: "Outcomes in Kidney Transplantation Between Veterans Affairs and Civilian Hospitals: Considerations in the Context of the MISSION Act". Annals of Surgery. 272:511. 2020
2020	Exacerbating Racial Disparities in Kidney Transplant: The Consequences of Geographic Redistribution. JAMA Surgery. 155:679-681. 2020
2020	Quantifying Sex-Based Disparities in Liver Allocation. JAMA Surgery. 155. 2020
2020	Use of Patient Navigators to Reduce Barriers in Living Donation and Living Donor Transplantation 2020
2020	Combined Thoracic-Kidney Transplantation Practices May Exacerbate Existing Geographic Disparities in Access to Deceased Donor Kidney Transplantation 2020
2020	Regional Variation in Appropriateness of Non-Hepatocellular Carcinoma Model for End-Stage Liver Disease Exception. Journal of The American College of Surgeons. 230:503-512.e8. 2020
2020	A Qualitative Assessment of the Living Donor Navigator Program to Identify Core Competencies and Promising Practices for Implementation 2020
2020	Donor-Recipient Relationship and Risk of ESKD in Live Kidney Donors of Varied Racial Groups. American Journal of Kidney Diseases. 75:333-341. 2020
2020	Tackling the weight list problem. American Journal of Transplantation. 20:329-330. 2020
2020	Enhanced Advocacy and Health Systems Training through Patient Navigation Increases Access to Living-donor Kidney Transplantation. Transplantation. 122-129. 2020
2020	Geographic differences in population health and expected organ supply in the Gulf Coast Region of the United States compared to non-Gulf States. Transplantation. 421-427. 2020
2020	Impact of Donor Hepatitis C Virus on Kidney Transplant Outcomes for Hepatitis C-positive Recipients in the Direct-acting Antiviral Era: Time to Revise the Kidney Donor Risk Index?. Transplantation. 1215-1228. 2020
2020	Positive crossmatch kidney transplantation: State of the art and future perspectives. Current Pharmaceutical Design. 26:3460-3467. 2020
2020	Redefining the Influence of Ethnicity on Simultaneous Kidney and Pancreas Transplantation Outcomes: A 15-year Single-center Experience. Annals of Surgery. 271:177-183. 2020
2020	Social determinants of health: Going beyond the basics to explore racial disparities in kidney transplantation. Transplantation. 1324-1325. 2020
2019	Patient Perspectives on Weight Management for Living Kidney Donation. Journal of Surgical Research. 244:50-56. 2019
2019	Donation approval among obese living kidney donor candidates: The impact of metabolic syndrome. Surgery. 166:940-946. 2019
2019	Get on with it!—A novel allocation strategy to reduce kidney discards. American Journal of Transplantation. 19:2971-2972. 2019
2019	Self-reported incident hypertension and long-term kidney function in living kidney donors compared with healthy nondonors. Clinical Journal of the American Society of Nephrology. 14:1493-1499. 2019
2019	Mitigating Racial and Sex Disparities in Access to Living Donor Kidney Transplantation: Impact of the Nation's Longest Single-center Kidney Chain. Annals of Surgery. 270:639-646. 2019
2019	Obesity and long-term mortality risk among living kidney donors. Surgery. 166:205-208. 2019
2019	Patient-reported outcome measures for life participation in kidney transplantation: A systematic review. American Journal of Transplantation. 19:2306-2317. 2019
2019	Center variation and risk factors for failure to complete 6 month postdonation follow-up among obese living kidney donors. Transplantation. 103:1450-1456. 2019
2019	Ethnic and age disparities in outcomes among liver transplant waitlist candidates. Transplantation. 103:1425-1432. 2019
2019	Time for reform in transplant program–specific reporting: AST/ASTS transplant metrics taskforce. American Journal of Transplantation. 19:1888-1895. 2019
2019	Establishing a core outcome measure for life participation: A standardized outcomes in nephrology-kidney transplantation consensus workshop report. Transplantation. 103:1199-1205. 2019
2019	Mortality and Kidney Transplantation Outcomes Among Hepatitis C Virus–Seropositive Maintenance Dialysis Patients: A Retrospective Cohort Study. American Journal of Kidney Diseases. 73:815-826. 2019
2019	Optimal timing of hepatitis C treatment among HIV/HCV coinfected ESRD patients: Pre- vs posttransplant. American Journal of Transplantation. 19:1806-1819. 2019
2019	Kidney transplantation in a HIV-positive recipient. Clinical Journal of the American Society of Nephrology. 14:614-616. 2019
2019	Disparity in access to kidney allograft offers among transplant candidates with human immunodeficiency virus. Clinical Transplantation. 33. 2019
2019	CYP3A5 genotype affects time to therapeutic tacrolimus level in pediatric kidney transplant recipients. Pediatric Transplantation. 23. 2019
2018	Implementing core outcomes in kidney disease: report of the Standardized Outcomes in Nephrology (SONG) implementation workshop. Kidney International. 94:1053-1068. 2018
2018	Population Health, Ethnicity, and Rate of Living Donor Kidney Transplantation. Transplantation. 102:2080-2087. 2018
2018	Can you hear me now? Patient preferences for evaluating kidney transplant centers. American Journal of Transplantation. 18:2624. 2018
2018	Population level outcomes and cost-effectiveness of hepatitis C treatment pre- vs postkidney transplantation. American Journal of Transplantation. 18:2483-2495. 2018
2018	Response to “It is time to revise the kidney allocation system to restore the pediatric advantage”. American Journal of Transplantation. 18:2367. 2018
2018	Expand the pool of living donors for kidney transplantation. Clinical Journal of the American Society of Nephrology. 13:1142-1143. 2018
2018	Impact of the new kidney allocation system A2/A2B → B policy on access to transplantation among minority candidates. American Journal of Transplantation. 18:1947-1953. 2018
2018	Decreasing deceased donor transplant rates among children (≤6 years) under the new kidney allocation system. American Journal of Transplantation. 18:1690-1698. 2018
2018	In Reply to ‘Core Assessment of Predonation Kidney Function: Clarification of the 2017 KDIGO Living Donor Guideline’. American Journal of Kidney Diseases. 72:155. 2018
2018	Apolipoprotein L1 and Chronic Kidney Disease Risk in Young Potential Living Kidney Donors. Annals of Surgery. 267:1161-1168. 2018
2018	Expanding clarity or confusion? Volatility of the 5-tier ratings assessing quality of transplant centers in the United States. American Journal of Transplantation. 18:1494-1501. 2018
2018	Response to: Regarding “HIV protease inhibitors and mortality following kidney transplantation”. American Journal of Transplantation. 18:1571. 2018
2018	Evaluation of Kidney Donors: Core Curriculum 2018. American Journal of Kidney Diseases. 71:737-747. 2018
2018	Assessing emergency department utilization in the era of population health. American Journal of Transplantation. 18:777-778. 2018
2018	Kidney transplantation and waitlist mortality rates among candidates registered as willing to accept a hepatitis C infected kidney. Transplant Infectious Disease. 20. 2018
2018	Landscape of ABO-Incompatible Live Donor Kidney Transplantation in the US. Journal of The American College of Surgeons. 226:615-621. 2018
2018	Long Cold Ischemia Times in Same Hospital Deceased Donor Transplants. Transplantation. 102:471-477. 2018
2018	Race but not Hepatitis C co-infection affects survival of HIV⁺ individuals on dialysis in contemporary practice. Kidney International. 93:706-715. 2018
2018	Patient and Kidney Allograft Survival in Recipients with End-Stage Renal Disease from Amyloidosis. Transplantation. 102:300-309. 2018
2018	Living Kidney Donor Phenotype and Likelihood of Postdonation Follow-up. Transplantation. 102:135-139. 2018
2018	Urologic malignancies in kidney transplantation. American Journal of Transplantation. 18:13-22. 2018
2017	Impact of Protease Inhibitor–Based Anti-Retroviral Therapy on Outcomes for HIV+ Kidney Transplant Recipients. American Journal of Transplantation. 17:3114-3122. 2017
2017	Apolipoprotein L1 Gene Effects on Kidney Transplantation. Seminars in Nephrology. 37:530-537. 2017
2017	Expanding the use of hepatitis C–viremic kidney donors. Kidney International. 92:1031-1033. 2017
2017	PROviding Better ACcess To ORgans: A comprehensive overview of organ-access initiatives from the ASTS PROACTOR Task Force. American Journal of Transplantation. 17:2546-2558. 2017
2017	Quantifying postdonation risk of ESRD in living kidney donors. Journal of the American Society of Nephrology. 28:2749-2755. 2017
2017	Effect of kidney donor hepatitis C virus serostatus on renal transplant recipient and allograft outcomes. Clinical Kidney Journal. 10:564-572. 2017
2017	Patterns of primary care utilization before and after living kidney donation. Clinical Transplantation. 31. 2017
2017	Risk of End-Stage Renal Disease in HIV-Positive Potential Live Kidney Donors. American Journal of Transplantation. 17:1823-1832. 2017
2017	The Authors Reply. Kidney International. 91:1256. 2017
2017	Abdominal lean muscle is associated with lower mortality among kidney waitlist candidates. Clinical Transplantation. 31. 2017
2017	Obesity increases the risk of end-stage renal disease among living kidney donors. Kidney International. 91:699-703. 2017
2017	Survival benefit of kidney transplantation in HIV-infected patients. Annals of Surgery. 265:604-608. 2017
2017	Lymphocyte-depleting induction therapy lowers the risk of acute rejection in African American pediatric kidney transplant recipients. Pediatric Transplantation. 21. 2017
2017	Access to kidney transplantation among HIV-infected waitlist candidates. Clinical Journal of the American Society of Nephrology. 12:467-475. 2017
2017	Increased Mortality and Graft Loss With Kidney Retransplantation Among Human Immunodeficiency Virus (HIV)–Infected Recipients. American Journal of Transplantation. 17:173-179. 2017
2017	Kidney transplantation of highly sensitized recipients under the new kidney allocation system: A reflection from five different transplant centers across the United States. Human Immunology. 78:30-36. 2017
2017	Survival benefit of transplantation with a deceased diabetic donor kidney compared with remaining on the waitlist. Clinical Journal of the American Society of Nephrology. 12:974-982. 2017
2016	Overcoming immunologic barriers to kidney transplantation: Desensitization and paired donation 2016
2016	Dosing Eculizumab for Antibody-Mediated Rejection in Kidney Transplantation: A Case Report. Transplantation Proceedings. 48:3099-3105. 2016
2016	Insurance Type and Solid Organ Transplantation Outcomes: A Historical Perspective on How Medicaid Expansion Might Impact Transplantation Outcomes. Journal of The American College of Surgeons. 223:611-620.e4. 2016
2016	Anti–Blood Group Antibodies in Intravenous Immunoglobulin May Complicate Interpretation of Antibody Titers in ABO-Incompatible Transplantation. American Journal of Transplantation. 16:2483-2486. 2016
2016	Identification of Optimal Donor–Recipient Combinations Among Human Immunodeficiency Virus (HIV)–Positive Kidney Transplant Recipients. American Journal of Transplantation. 16:2377-2383. 2016
2016	Induction Immunosuppression and Clinical Outcomes in Kidney Transplant Recipients Infected With Human Immunodeficiency Virus. American Journal of Transplantation. 16:2368-2376. 2016
2016	Inpatient mortality among solid organ transplant recipients hospitalized for sepsis and severe sepsis. Clinical Infectious Diseases. 63:186-194. 2016
2016	A systematic review of the use of expandable cages in the cervical spine. Neurosurgical Review. 39:1-11. 2016
2016	Long-Term outcomes after liver transplantation among human immunodeficiency virus-infected recipients. Transplantation. 100:141-146. 2016
2015	Hospital-onset Clostridium difficile infection among solid organ transplant recipients. American Journal of Transplantation. 15:2970-2977. 2015
2015	A national study of outcomes among HIV-infected kidney transplant recipients. Journal of the American Society of Nephrology. 26:2222-2229. 2015
2015	Center-Level Experience and Kidney Transplant Outcomes in HIV-Infected Recipients. American Journal of Transplantation. 15:2096-2104. 2015
2015	The biomechanics of pedicle screw augmentation with cement 2015
2015	A Systematic Assessment of the Use of Platelet-Rich Plasma in Spinal Fusion. Annals of Biomedical Engineering. 43:1057-1070. 2015
2015	The impact of proposed changes in liver allocation policy on cold ischemia times and organ transportation costs. American Journal of Transplantation. 15:541-546. 2015
2015	Identification of strategies to facilitate organ donation among african americans using the nominal group technique. Clinical Journal of the American Society of Nephrology. 10:286-293. 2015
2014	To whom goes the kidney? 2014
2014	The authors' reply. Transplantation. 97. 2014
2014	Resource utilization associated with procurement of transplantable organs from donors that do not meet OPTN eligible death criteria. Transplantation. 97:1043-1048. 2014
2014	Immunosuppression regimen and the risk of acute rejection in HIV-infected kidney transplant recipients. Transplantation. 97:446-450. 2014
2014	Eculizumab and splenectomy as salvage therapy for severe antibody-mediated rejection after HLA-incompatible kidney transplantation. Transplantation. 98:857-863. 2014
2014	Is there a role for detection of complement-binding antibodies in kidney transplantation?. American Journal of Kidney Diseases. 63:558-560. 2014
2013	What liver transplant outcomes can be expected in the uninsured who become insured via the affordable care act?. American Journal of Transplantation. 13:1533-1540. 2013
2012	Donor-derived organ transplant transmission of coccidioidomycosis. Transplant Infectious Disease. 14:300-304. 2012
2012	Re: Desensitization in HLA-incompatible kidney recipients and survival 2012
2012	In vitro and ex vivo delivery of short hairpin RNAs for control of hepatitis C viral transcript expression. Archives of Surgery. 147:384-387. 2012
2011	Late graft loss among pediatric recipients of DCD kidneys. Clinical Journal of the American Society of Nephrology. 6:2705-2711. 2011
2011	Outcomes of renal transplants from centers for disease control and prevention high-risk donors with prospective recipient viral testing: A single-center experience. Archives of Surgery. 146:1261-1266. 2011
2011	Desensitization in HLA-incompatible kidney recipients and survival. New England Journal of Medicine. 365:318-326. 2011
2011	Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients.. Hepatic Medicine : Evidence and Research. 3:53-62. 2011
2010	Stem cell mobilization is life saving in an animal model of acute liver failure. Annals of Surgery. 252:591-595. 2010
2010	Eculizumab, bortezomib and kidney paired donation facilitate transplantation of a highly sensitized patient without vascular access. American Journal of Transplantation. 10:2154-2160. 2010
2010	Proinflammatory events and HLA antibodies.. American Journal of Transplantation. 10:956. 2010
2010	Renal transplantation in HIV-positive recipients. Current Infectious Disease Reports. 12:71-75. 2010
2009	Impact of medicare coverage on disparities in access to simultaneous pancreas and kidney transplantation. American Journal of Transplantation. 9:2785-2791. 2009
2009	Increased risk of graft loss from hepatic artery thrombosis after liver transplantation with older donors 2009
2009	Stem Cells and the Liver: Clinical Applications in Transplantation. Advances in Surgery. 43:35-51. 2009
2009	Successful liver transplantation for Budd-Chiari syndrome in a patient with paroxysmal nocturnal hemoglobinuria treated with the anti-complement antibody eculizumab 2009
2009	Rapid accomodation of an a1 renal allograft after preconditioning for ABO-incompatible transplantation. Contributions to Nephrology. 162:35-46. 2009
2009	Recruitment of host progenitor cells in rat liver transplants. Hepatology. 49:587-597. 2009
2009	ABO incompatible renal transplantation: A paradigm ready for broad implementation. Transplantation. 87:1246-1255. 2009
2009	ABO-incompatible deceased donor liver transplantation in the United States: A national registry analysis 2009
2009	C4d deposition without rejection correlates with reduced early scarring in ABO-incompatible renal allografts. Journal of the American Society of Nephrology. 20:197-204. 2009
2009	Proinflammatory events are associated with significant increases in breadth and strength of HLA-specific antibody. American Journal of Transplantation. 9:2136-2139. 2009
2009	Renal transplant in HIV-positive patients: Long-term outcomes and risk factors for graft loss. Archives of Surgery. 144:83-86. 2009
2009	The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection. American Journal of Transplantation. 9:231-235. 2009
2008	Prolonged waiting times for liver transplantation in obese patients. Annals of Surgery. 248:863-870. 2008
2008	Donor ethnicity influences outcomes following deceased-donor kidney transplantation in black recipients. Journal of the American Society of Nephrology. 19:2011-2019. 2008
2008	Generation of humanized animal livers using embryoid body-derived stem cell transplant. Annals of Surgery. 248:487-491. 2008
2008	Can Machine Perfusion Decrease the Likelihood of Discard Among Biopsied Kidneys?. Transplantation Proceedings. 40:1029-1031. 2008
2008	Declining outcomes in simultaneous liver-kidney transplantation in the MELD era: Ineffective usage of renal allografts. Transplantation. 85:935-942. 2008
2008	Effect modification in liver allografts with prolonged cold ischemic time. American Journal of Transplantation. 8:658-666. 2008
2008	Obesity impacts access to kidney transplantation. Journal of the American Society of Nephrology. 19:349-355. 2008
2007	ABO-incompatible transplantation: Less may be more. Transplantation. 84. 2007
2007	Minimizing risk associated with elderly liver donors by matching to preferred recipients. Hepatology. 46:1907-1918. 2007
2007	Twenty years of liver transplantation for Budd-Chiari syndrome: A national registry analysis 2007
2007	Desensitization protocols for crossing human leukocyte antigen and ABO incompatible barriers. Current Opinion in Organ Transplantation. 12:371-378. 2007
2007	Outcomes of kidneys from donors after cardiac death: Implications for allocation and preservation. American Journal of Transplantation. 7:1797-1807. 2007
2007	The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection. American Journal of Transplantation. 7:842-846. 2007
2007	Cold ischemia time and allograft outcomes in live donor renal transplantation: Is live donor organ transport feasible?. American Journal of Transplantation. 7:99-107. 2007
2006	Factors affecting graft survival after liver transplantation from donation after cardiac death donors. Transplantation. 82:1683-1688. 2006
2006	Biliary cystic disease. Current Treatment Options in Gastroenterology. 9:107-112. 2006
2006	Rescue splenectomy for severe acute antibody-mediated rejection.. Clinical Transplants. 518-520. 2006
2005	Inflammatory pseudotumor of the liver. Journal of Hepato-Biliary-Pancreatic Surgery. 12:314-316. 2005

Chapter

Year	Title	Altmetric
2019	Kidney allocation. 371-378. 2019
2015	Management of Portal Hypertensive Hemorrhage. 510-513. 2015
2012	Consider parvovirus B19 infection in patients with anemia or pancytopenia 2012
2012	Keep patients with dural tears flat for 24-48 hours 2012
2012	Place the tip of a central venous catheter at the junction of the superior vena cava and atrium 2012

Research Overview

abdominal transplantation, incompatible organ transplantation, transplantation of HIV-infected end-stage patients, outcomes and behavioral research focused on health disparities